OFFICIAL PUBLICATION OF

by its subsidiary APPco

PSA launches APF23

Megan Haggan 08/05/2015

A significant number of medicines have the potential to pose a health and safety risk as a result of unintended exposure when people other than the patient – such as carers, family members or healthcare professionals – handle the medicine, the PSA has highlighted. To help protect people from such exposure, the latest edition of

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Consumer confusion, pharmacist frustration’ if current system continues

The first and foremost role of "expanded scope" is the HMR and collaborative medication management. A clear no brainer which…

Big Pharma

‘I can feel the walls closing in on me as this snowballs’

I'm yet to encounter a corporate provider, Debbie, with the benefits you describe around quality improvement with the corporate business…

Kelly Abbott

‘Consumer confusion, pharmacist frustration’ if current system continues

I welcome Mark's move, at least someone talks about it. But like any push at the forefront, it comes with…

Benjamyn Sung

‘I can feel the walls closing in on me as this snowballs’

I would argue quality varies in any profession. Most GPs will not refer to a provider where the quality is…

Big Pharma

PSA launches APF23

Previous Clinical tips: macular degeneration explained

Next NPS on antibiotic resistance: 'Winter is coming'

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous Clinical tips: macular degeneration explained

Next NPS on antibiotic resistance: 'Winter is coming'

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.